VANDETANIB (300 MG) IN METASTATIC HEREDITARY MEDULLARY THYROID CANCER: A PHASE II OPEN-LABEL STUDY Posted on by Read More
THE EFFECT OF RITUXIMAB ON IL-6/SIL-6R AND CXCL10 SECRETION AND TSH-RECEPTOR STIMULATING ANTIBODIES IN PATIENTS WITH ACTIVE THYROID-ASSOCIATED ORBITOPATHY Posted on by Read More
EFFECTS OF SELENIUM AND IODINE DEPLETION/REPLETION ON BEHAVIORS OF ADULT C57BL/6 MICE Posted on by Read More
THYROID FUNCTION STATUS, CARDIOVASCULAR RISK FACTORS AND MORTALITY IN OLDER PERSONS Posted on by Read More
MODULATION OF IODIDE UPTAKE AND RETINOIC ACID RECEPTORS (RAR AND RXR) EXPRESSION BY THYROTROPIN AND RETINOIC ACID Posted on by Read More
PRIMARY TUMOUR DIAMETER AS A RISK FACTOR FOR METASTASES IN DIFFERENTIATED THYROID CARCINOMA Posted on by Read More
IODINE NUTRITION SURVEY AFTER UNIVERSAL SALT IODIZATION (USI) IMPLEMENTATION; THE CONSEQUENCE OF LOW UIC ON THYROID FUNCTION IN PREGNANT WOMEN (PW) AND NEONATE (OC) AT BIRTH Posted on by Read More
THYROID HORMONE THERAPY IN HYPOTHYROID PATIENTS UNDERGOING CORONARY ANGIOGRAPHY AND CORONARY ARTERIAL BYPASS SURGERY Posted on by Read More
DIFFERENT IN VITRO ACTIVITIES OF SPORADIC, FAMILIAR AND SOMATIC TSH-RECEPTOR (TSHR) MUTATIONS Posted on by Read More
MEASUREMENT OF IL-18, IL-10, IL-15 AND TRANSFORMING GROWTH FACTOR ETA 1 IN SERA OF PATIENTS WITH HASHIMOTOS THYROIDITIS Posted on by Read More